Morepen Laboratories Limited (MOREPENLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 20.4B |
| Enterprise Value | 21.79B |
| P/E Ratio | 37.5 |
| PEG Ratio | 0.73 |
| Price/Sales Ratio | 2.7 |
| Price/Book Ratio | 4.22 |
| Enterprise/Revenue | 2.7 |
| Enterprise/EBITDA | 23.2 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.08 |
| Return On Assets | 0 |
| Return On Equity | 0.12 |
| Revenue | 18.06B |
| Revenue/Share | 35.6 |
| Gross Profit | 6.82B |
| EBITDA | 1.73B |
| Net Income | 948.77M |
| Diluted EPS | 1.73 |
| Total Cash | 916.99M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 22.76 |
| 52-Week Change | 95.82 |
| 52-Week High | 97.5 |
| 52-Week Low | 33.05 |
| Moving Average 50 Days | 63.94 |
| Moving Average 200 Days | 46.58 |
| Average Volume | 19.25M |
| Shares Outstanding | 547.95M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.21 |
| Payout Ratio | 0.08 |
| Last Split Factor | 5:1 |
| Last Split Date | November 07, 2000 |